|
Volumn 50, Issue 5, 2009, Pages 987-993
|
Validation of a new HPLC method for determination of midazolam and its metabolites: Application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbits
|
Author keywords
CYP3A; HPLC; Midazolam; Pharmacokinetics; Therapeutic drug monitoring
|
Indexed keywords
1 HYDROXYMIDAZOLAM;
4 HYDROXYMIDAZOLAM;
CYTOCHROME P450 3A;
DRUG METABOLITE;
HYDROXYL GROUP;
LORAZEPAM;
MIDAZOLAM;
UNCLASSIFIED DRUG;
ACCURACY;
ADULT;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CALIBRATION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG ELIMINATION;
DRUG HALF LIFE;
ENZYME ACTIVITY;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
INTERMETHOD COMPARISON;
LIQUID LIQUID EXTRACTION;
MASS FRAGMENTOGRAPHY;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
NORMAL HUMAN;
PRIORITY JOURNAL;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ULTRAVIOLET RADIATION;
VALIDATION STUDY;
ADULT;
ANIMALS;
CALIBRATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYTOCHROME P-450 CYP3A;
DRUG MONITORING;
FEMALE;
HUMANS;
LIVER;
MICROSOMES;
MIDAZOLAM;
OXYGEN;
QUALITY CONTROL;
RABBITS;
REPRODUCIBILITY OF RESULTS;
|
EID: 70349171285
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2009.07.004 Document Type: Article |
Times cited : (25)
|
References (34)
|